Moderna
Search results
23 hours ago · Vertex Pharmaceuticals (NASDAQ: VRTX) transformed the world of cystic fibrosis (CF) treatment when it launched its first product for the disease 12 years ago. Since then, it's built a CF treatment ...
1 day ago · With Vertex Pharmaceuticals (VRTX 0.91%) announcing on June 21 that its therapy VX-880 helped nearly all of the patients with diabetes in a clinical trial to reduce or eliminate their need for ...
3 days ago · Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.
4 days ago · Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
3 days ago · Vertex Is Writing A New Playbook For Pharma R&D. And It's Working. Vertex Pharmaceuticals (NDAQ: VRTX) stands today as a top 20 pharma company with over a $100 billion market cap. But this biotech beacon has ridden a bumpy path to its current perch and, along the way...
3 days ago · Latest Vertex Pharmaceuticals Inc (VRTX:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
5 days ago · Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
